These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 29047145

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Exploring Emergency Department Provider Experiences With and Perceptions of Weight-Based Versus Individualized Vaso-Occlusive Treatment Protocols in Sickle Cell Disease.
    Knight LMJ, Onsomu EO, Bosworth HB, Crawford RD, DeMartino T, Glassberg J, Paice JA, Miller CN, Richardson L, Tanabe P.
    Adv Emerg Nurs J; 2019; 41(1):86-97. PubMed ID: 30702538
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Improving the Management of Vaso-Occlusive Episodes in the Pediatric Emergency Department.
    Kavanagh PL, Sprinz PG, Wolfgang TL, Killius K, Champigny M, Sobota A, Dorfman D, Barry K, Miner R, Moses JM.
    Pediatrics; 2015 Oct; 136(4):e1016-25. PubMed ID: 26391933
    [Abstract] [Full Text] [Related]

  • 7. Low-Dose Ketamine Infusion for Adjunct Management during Vaso-occlusive Episodes in Adults with Sickle Cell Disease: A Case Series.
    Palm N, Floroff C, Hassig TB, Boylan A, Kanter J.
    J Pain Palliat Care Pharmacother; 2018 Mar; 32(1):20-26. PubMed ID: 29791238
    [Abstract] [Full Text] [Related]

  • 8. A comparison of the effect of patient-specific versus weight-based protocols to treat vaso-occlusive episodes in the emergency department.
    Tanabe P, Ibemere S, Pierce AE, Freiermuth CE, Bosworth HB, Yang H, Osunkwo I, Paxton JH, Strouse JJ, Miller J, Paice JA, Veeramreddy P, Kavanagh PL, Wilkerson RG, Hughes R, Barnhart HX.
    Acad Emerg Med; 2023 Dec; 30(12):1210-1222. PubMed ID: 37731093
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Management of vaso-occlusive episodes in the day hospital decreases admissions in children with sickle cell disease.
    Karkoska K, Appiah-Kubi A, Rocker J, Stoffels G, Aygun B.
    Br J Haematol; 2019 Sep; 186(6):855-860. PubMed ID: 31148158
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Vaso-occlusive episodes in older children with sickle cell disease: emergency department management and pain assessment.
    Frei-Jones MJ, Baxter AL, Rogers ZR, Buchanan GR.
    J Pediatr; 2008 Feb; 152(2):281-5. PubMed ID: 18206703
    [Abstract] [Full Text] [Related]

  • 18. Effect of ketorolac in pediatric sickle cell vaso-occlusive pain crisis.
    Hardwick WE, Givens TG, Monroe KW, King WD, Lawley D.
    Pediatr Emerg Care; 1999 Jun; 15(3):179-82. PubMed ID: 10389953
    [Abstract] [Full Text] [Related]

  • 19. Use of a clinical pathway to improve the acute management of vaso-occlusive crisis pain in pediatric sickle cell disease.
    Ender KL, Krajewski JA, Babineau J, Tresgallo M, Schechter W, Saroyan JM, Kharbanda A.
    Pediatr Blood Cancer; 2014 Apr; 61(4):693-6. PubMed ID: 24249617
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.